1. Center for Biomedical Network Research on Rare Diseases (CIBERER), Institute of Health Carlos III, Valencia, Spain;
2. INCLIVA Biomedical Research Institute, Valencia, Spain;
3. Department Physiology, School of Medicine and Dentistry, Universitat de València (UV), Valencia, Spain;
4. Epigenetics Research Platform (CIBERER/UV/INCLIVA), Valencia, Spain;
5. EpiDisease S.L. Spin-Off of CIBERER (ISCIII), Valencia, Spain;
6. Department of Biology, University of Alabama at Birmingham, Birmingham, AL, USA;
7. INCLIVA Biobank, Valencia, Spain;
8. Institute of Medical and Molecular Genetics (INGEMM), IdiPAZ, Hospital Universitario La Paz, Universidad Autónoma de Madrid, Madrid, Spain